Adults 18 to 25, female only, with Acute Pain. Patients with the condition only — healthy volunteers not accepted.
Results — posted to ClinicalTrials.gov
Per-arm endpoint measurements with 95% confidence intervals where reported. Source: trial results section.
Pain TolerancePrimary· 4 hours After Administration
The ischemic discomfort task applied a sphygmomanometer (blood pressure cuff) 5 cm below their elbow. The cuff was inflated to 200 mmHg. Pain tolerance was measured by how long they could tolerate the ischemic discomfort task. However, task was only allowed to last for 6 minutes
Group
Value
95% CI
Testosterone
224.20500
± 91.144110
Placebo
224.92615
± 94.080395
Changes Testosterone LevelsSecondary· Prior to Intervention (Baseline), 15 minutes Post Intervention
The measured testosterone levels in the participants before and after receiving the intervention
Group
Value
95% CI
Testosterone
580.299600
± 45.919951749402
Placebo
38.3972
± 10.859257363884
Changes Estradiol LevelsSecondary· Prior to Intervention (Baseline), 15 minutes Post Intervention
The measured estradiol levels in the participants before and after receiving the intervention.
Group
Value
95% CI
Testosterone
-0.903160000000
± 0.1943390807362
Placebo
0.1801549999999
± 0.0950549798844
Changes Progesterone LevelsSecondary· Prior to Intervention (Baseline), 15 minutes Post Intervention
he measured progesterone levels in the participants before and after receiving the intervention.
Group
Value
95% CI
Testosterone
-423.63719
± 72.274306309941
Placebo
29.381135
± 59.866738560717
Sponsor's own description
This trial examined how the administration of exogenous testosterone would influence pain tolerance and other endogenous steroids (i.e. estradiol and progesterone).
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
NCT06149065 — Factors Associated With the Acne Severity Among Transmen Population: a Cross-sectional Study
· completed
NCT02938923 — Starting a Testosterone and Exercise Program After Hip Injury
· Phase 3
· completed
NCT02799277 — A Multinomial Process Model of Moral Judgment
· Phase 4
· completed
Other recruiting trials for Acute Pain
Currently open trials in the same condition.
NCT06779604 — Dexmedetomidine and Dexamethasone Added as Adjuvant Infraclavicular Brachial Plexus Block in Upper Limb Surgery
· recruiting
NCT07348419 — Quadro-Iliac vs Thoracolumbar Interfascial Plane Block for Analgesia After Single-Level Lumbar Disc Surgery
· NA
· recruiting
NCT07335159 — Does Patient Testimonial Improve the Pain Relief Derived From a Brief Intervention
· NA
· recruiting
NCT07348523 — Comparison of the Postoperative Analgesic Efficacy of Classical and Modified Erector Spinae Plane Blocks After Lumbar Sp
· NA
· recruiting
NCT07336264 — Characterization of Acute Pain
· recruiting
Other University of New Mexico trials
Trials by the same sponsor.
NCT07484906 — Precision Phenotyping of Behavioral Risk and Response to Electromagnetic and Psychedelic Therapies
· Phase 2
· withdrawn
NCT07506395 — Group Psilocybin-Assisted Therapy for Post-Traumatic Stress Disorder
· Phase 1
· not yet recruiting
NCT07265973 — PREPARE: Perioperative REhabilitation Around Vaginal Prolapse RepAir Surgery for Recovery Enhancement
· NA
· recruiting
NCT06982443 — Wellness, Alcohol, Vitals, and Emotions
· NA
· recruiting
NCT06940609 — Magnetic Resonance Analysis of Neural Inflammatory Factors and External Stimulation
· Phase 2
· recruiting
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University of New Mexico
Last refreshed: 5 August 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05781685.